Stocks · News reference
Barclays Maintains Overweight on Nutrien, Lowers Price Target to $78
Barclays analyst Benjamin Theurer maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $81 to $78.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Top 3 Materials Stocks That Could Sink Your Portfolio This Month
As of Sept. 1, 2026, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares
Goldman Sachs Nasdaq-100 ETF, Nutrien And More: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Bryn Talkington, managing partner of Requisite Capital Management, said Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ: GPIQ) has a 10.5% yield.
CNBC Halftime Report Final Trades: Nutrien, Goldman Sachs Nasdaq-100 Premium Income ETF, GXO Logistics, iShares U.S. Financial ETF